[Relationship Between Expression of Inhibitory Killer Cell Immunoglobulin-Like Receptor HLA-Cw Ligand and Susceptibility to Inflammatory Bowel Disease].

Hui-Xia Zhang,Ji-Chang Li,Zhan-Ju Liu
DOI: https://doi.org/10.3321/j.issn:0376-2491.2008.44.004
2008-01-01
Abstract:OBJECTIVE:To investigate the distribution of different phenotypes of inhibitory killer cell immunoglobulin-like receptor (iKIR) and its ligand HLA-Cw in patients with inflammatory bowel disease (IBD), and to explore whether iKIR/HLA-Cw combinations are associated with IBD susceptibility.METHODS:Peripheral blood samples were collected from 100 patients with ulcerative colitis (UC), 73 patients with Crohn's disease, and 106 randomly selected ethnically matched healthy controls. Polymerase chain reaction with sequence-specific primers was used to analyze the iKIR phenotypes, and the HLA-Cw phenotypes was examined with HLA-C LOCUS SSP UNITRAY kit, and the combination of HLA-Cw and its corresponding iKIR in individual was analyzed subsequently.RESULTS:The KIR2DL1 and KIR2DL3 gene phenotype frequencies in UC patients were 0.710 and 0.620 respectively, both significantly lower than those in healthy controls (0.896, chi(2) = 11.405 P = 0.001, and 0.821, chi(2) = 10.362 P = 0.001 respectively). The KIR2DL1 gene phenotype frequency in CD patients was 0.740, significantly lower than that in healthy controls (0.896, chi(2) = 7.589, P = 0.006). The KIR2DL1 HLA-C2 combination (2DL1(+)-HLA-C2(+)) in UC patients and CD patients were 0.380 and 0.411 respectively, both significantly lower than that in healthy controls (0.575, chi(2) = 7.876 P = 0.005 and 0.575, chi(2) = 4.681 P = 0.030 respectively).CONCLUSION:The susceptibility to IBD is associated with decreased KIR2DL1-HLA-C2 combination.
What problem does this paper attempt to address?